List of Chapters/Sections(Table Of Content)
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Transdermal Patch Revenue
1.4 Market Analysis by Type
1.4.1 Global Transdermal Patch Market Size Growth Rate by Type: 2021 VS 2027
1.4.2 Methyl Salicylate-Based Patch
1.4.3 Rivastigmine Transdermal Patch
1.4.4 Fentanyl Transdermal Patch
1.4.5 Lidocaine Patch
1.4.6 Diclofenac Patch
1.4.7 Nicotine Transdermal Patch
1.5 Market by Application
1.5.1 Global Transdermal Patch Market Share by Application: 2022-2027
1.5.2 Rx Channel
1.5.3 OTC Channel
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Transdermal Patch Market
1.8.1 Global Transdermal Patch Market Status and Outlook (2016-2027)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Transdermal Patch Production Capacity Market Share by Manufacturers (2016-2021)
2.2 Global Transdermal Patch Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Transdermal Patch Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Transdermal Patch Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Transdermal Patch Sales Volume Market Share by Region (2016-2021)
3.2 Global Transdermal Patch Sales Revenue Market Share by Region (2016-2021)
3.3 North America Transdermal Patch Sales Volume
3.3.1 North America Transdermal Patch Sales Volume Growth Rate (2016-2021)
3.3.2 North America Transdermal Patch Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.4 East Asia Transdermal Patch Sales Volume
3.4.1 East Asia Transdermal Patch Sales Volume Growth Rate (2016-2021)
3.4.2 East Asia Transdermal Patch Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.5 Europe Transdermal Patch Sales Volume (2016-2021)
3.5.1 Europe Transdermal Patch Sales Volume Growth Rate (2016-2021)
3.5.2 Europe Transdermal Patch Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.6 South Asia Transdermal Patch Sales Volume (2016-2021)
3.6.1 South Asia Transdermal Patch Sales Volume Growth Rate (2016-2021)
3.6.2 South Asia Transdermal Patch Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.7 Southeast Asia Transdermal Patch Sales Volume (2016-2021)
3.7.1 Southeast Asia Transdermal Patch Sales Volume Growth Rate (2016-2021)
3.7.2 Southeast Asia Transdermal Patch Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.8 Middle East Transdermal Patch Sales Volume (2016-2021)
3.8.1 Middle East Transdermal Patch Sales Volume Growth Rate (2016-2021)
3.8.2 Middle East Transdermal Patch Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.9 Africa Transdermal Patch Sales Volume (2016-2021)
3.9.1 Africa Transdermal Patch Sales Volume Growth Rate (2016-2021)
3.9.2 Africa Transdermal Patch Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.10 Oceania Transdermal Patch Sales Volume (2016-2021)
3.10.1 Oceania Transdermal Patch Sales Volume Growth Rate (2016-2021)
3.10.2 Oceania Transdermal Patch Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.11 South America Transdermal Patch Sales Volume (2016-2021)
3.11.1 South America Transdermal Patch Sales Volume Growth Rate (2016-2021)
3.11.2 South America Transdermal Patch Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
3.12 Rest of the World Transdermal Patch Sales Volume (2016-2021)
3.12.1 Rest of the World Transdermal Patch Sales Volume Growth Rate (2016-2021)
3.12.2 Rest of the World Transdermal Patch Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)
4 North America
4.1 North America Transdermal Patch Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Transdermal Patch Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Transdermal Patch Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Transdermal Patch Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Transdermal Patch Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Transdermal Patch Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Transdermal Patch Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Transdermal Patch Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Transdermal Patch Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Transdermal Patch Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Transdermal Patch Sales Volume Market Share by Type (2016-2021)
14.2 Global Transdermal Patch Sales Revenue Market Share by Type (2016-2021)
14.3 Global Transdermal Patch Sales Price by Type (2016-2021)
15 Consumption Analysis by Application
15.1 Global Transdermal Patch Consumption Volume by Application (2016-2021)
15.2 Global Transdermal Patch Consumption Value by Application (2016-2021)
16 Company Profiles and Key Figures in Transdermal Patch Business
16.1 Hisamitsu Pharmaceutical
16.1.1 Hisamitsu Pharmaceutical Company Profile
16.1.2 Hisamitsu Pharmaceutical Transdermal Patch Product Specification
16.1.3 Hisamitsu Pharmaceutical Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.2 Johnson & Johnson
16.2.1 Johnson & Johnson Company Profile
16.2.2 Johnson & Johnson Transdermal Patch Product Specification
16.2.3 Johnson & Johnson Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.3 Novartis
16.3.1 Novartis Company Profile
16.3.2 Novartis Transdermal Patch Product Specification
16.3.3 Novartis Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.4 UCB Pharma
16.4.1 UCB Pharma Company Profile
16.4.2 UCB Pharma Transdermal Patch Product Specification
16.4.3 UCB Pharma Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.5 Mylan
16.5.1 Mylan Company Profile
16.5.2 Mylan Transdermal Patch Product Specification
16.5.3 Mylan Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.6 Teva Pharmaceutical
16.6.1 Teva Pharmaceutical Company Profile
16.6.2 Teva Pharmaceutical Transdermal Patch Product Specification
16.6.3 Teva Pharmaceutical Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.7 Nitto Denko
16.7.1 Nitto Denko Company Profile
16.7.2 Nitto Denko Transdermal Patch Product Specification
16.7.3 Nitto Denko Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.8 Gr?nenthal
16.8.1 Gr?nenthal Company Profile
16.8.2 Gr?nenthal Transdermal Patch Product Specification
16.8.3 Gr?nenthal Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.9 IBSA Group
16.9.1 IBSA Group Company Profile
16.9.2 IBSA Group Transdermal Patch Product Specification
16.9.3 IBSA Group Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.10 GSK
16.10.1 GSK Company Profile
16.10.2 GSK Transdermal Patch Product Specification
16.10.3 GSK Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.11 Luye Pharma Group
16.11.1 Luye Pharma Group Company Profile
16.11.2 Luye Pharma Group Transdermal Patch Product Specification
16.11.3 Luye Pharma Group Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.12 Pfizer
16.12.1 Pfizer Company Profile
16.12.2 Pfizer Transdermal Patch Product Specification
16.12.3 Pfizer Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.13 Chattem
16.13.1 Chattem Company Profile
16.13.2 Chattem Transdermal Patch Product Specification
16.13.3 Chattem Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.14 Dr Reddy`s Laboratories
16.14.1 Dr Reddy`s Laboratories Company Profile
16.14.2 Dr Reddy`s Laboratories Transdermal Patch Product Specification
16.14.3 Dr Reddy`s Laboratories Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.15 Bayer
16.15.1 Bayer Company Profile
16.15.2 Bayer Transdermal Patch Product Specification
16.15.3 Bayer Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.16 Mundipharma
16.16.1 Mundipharma Company Profile
16.16.2 Mundipharma Transdermal Patch Product Specification
16.16.3 Mundipharma Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.17 Endo International
16.17.1 Endo International Company Profile
16.17.2 Endo International Transdermal Patch Product Specification
16.17.3 Endo International Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
16.18 Beijing Tide Pharmaceutical
16.18.1 Beijing Tide Pharmaceutical Company Profile
16.18.2 Beijing Tide Pharmaceutical Transdermal Patch Product Specification
16.18.3 Beijing Tide Pharmaceutical Transdermal Patch Production Capacity, Revenue, Price and Gross Margin (2016-2021)
17 Transdermal Patch Manufacturing Cost Analysis
17.1 Transdermal Patch Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Transdermal Patch
17.4 Transdermal Patch Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Transdermal Patch Distributors List
18.3 Transdermal Patch Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Transdermal Patch (2022-2027)
20.2 Global Forecasted Revenue of Transdermal Patch (2022-2027)
20.3 Global Forecasted Price of Transdermal Patch (2016-2027)
20.4 Global Forecasted Production of Transdermal Patch by Region (2022-2027)
20.4.1 North America Transdermal Patch Production, Revenue Forecast (2022-2027)
20.4.2 East Asia Transdermal Patch Production, Revenue Forecast (2022-2027)
20.4.3 Europe Transdermal Patch Production, Revenue Forecast (2022-2027)
20.4.4 South Asia Transdermal Patch Production, Revenue Forecast (2022-2027)
20.4.5 Southeast Asia Transdermal Patch Production, Revenue Forecast (2022-2027)
20.4.6 Middle East Transdermal Patch Production, Revenue Forecast (2022-2027)
20.4.7 Africa Transdermal Patch Production, Revenue Forecast (2022-2027)
20.4.8 Oceania Transdermal Patch Production, Revenue Forecast (2022-2027)
20.4.9 South America Transdermal Patch Production, Revenue Forecast (2022-2027)
20.4.10 Rest of the World Transdermal Patch Production, Revenue Forecast (2022-2027)
20.5 Forecast by Type and by Application (2022-2027)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)
20.5.2 Global Forecasted Consumption of Transdermal Patch by Application (2022-2027)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Transdermal Patch by Country
21.2 East Asia Market Forecasted Consumption of Transdermal Patch by Country
21.3 Europe Market Forecasted Consumption of Transdermal Patch by Countriy
21.4 South Asia Forecasted Consumption of Transdermal Patch by Country
21.5 Southeast Asia Forecasted Consumption of Transdermal Patch by Country
21.6 Middle East Forecasted Consumption of Transdermal Patch by Country
21.7 Africa Forecasted Consumption of Transdermal Patch by Country
21.8 Oceania Forecasted Consumption of Transdermal Patch by Country
21.9 South America Forecasted Consumption of Transdermal Patch by Country
21.10 Rest of the world Forecasted Consumption of Transdermal Patch by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer
